For the year ending 2025-12-31, LXRX has $184,987K in assets. $77,449K in debts. $34,326K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 34,326 | |||
| Short-term investments | 61,904 | |||
| Accounts receivable, net | 2,384 | |||
| Inventory | 281 | |||
| Prepaid expenses and other current assets | 3,000 | |||
| Total current assets | 101,895 | |||
| Property and equipment, net | 1,863 | |||
| Goodwill | 44,543 | |||
| Operating lease right-of-use-assets | 7,318 | |||
| Restricted cash | 29,000 | |||
| Other assets | 368 | |||
| Total assets | 184,987 | |||
| Accounts payable | 3,083 | |||
| Accrued liabilities | 13,189 | |||
| Current portion of long-term debt | 4,595 | |||
| Total current liabilities | 20,867 | |||
| Long-term debt, net | 49,408 | |||
| Other long-term liabilities | 7,174 | |||
| Total liabilities | 77,449 | |||
| Common stock, 0.001 par value 450,000,000 shares authorized 365,848,216 and 363,020,303 shares issued, respectively | 366 | |||
| Additional paid-in capital | 2,129,912 | |||
| Accumulated deficit | -2,017,583 | |||
| Accumulated other comprehensive income | 30 | |||
| Treasury stock, at cost, 2,381,939 and 1,528,008 shares, respectively | 5,187 | |||
| Total stockholders' equity | 107,538 | |||
| Total liabilities and stockholders equity | 184,987 | |||
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)